Paradigm Peptides Review: Supplier Comparison — What Competitors Do Differently
Paradigm Peptides Not published No. Generic COAs only 91.4% mean (SD 4.2%) 91–98% (inconsistent) Store credit after dispute Functional but unreliable for precision work. Batch variability too high for reproducible research Real Peptides Published per batch Yes
Review the documented criteria directly; this page does not generate a winner or rating.
- Paradigm Peptides
- Not published
- No. Generic COAs only
- 91.4% mean (SD 4.2%)
- 91–98% (inconsistent)
- Store credit after dispute
- Functional but unreliable for precision work. Batch variability too high for reproducible research
- Real Peptides
- Published per batch
- Yes. Scannable QR codes
- 98.7% mean (SD 1.1%)
- 97.5–99.2% (consistent)
- Full refund + replacement if tested below spec
- Small-batch synthesis with exact sequencing guarantees. Built for labs requiring reproducibility
- Peptide Sciences
- Quarterly third-party audits
- Yes. Downloadable PDFs
- 96.8% mean (SD 2.3%)
- 95–99%
- Refund if discrepancy >3%
- Mid-tier reliability. Better than Paradigm, less stringent than Real Peptides
- Swiss Chems
- Self-tested only
- No
- 89–95% (customer reports)
- Variable
- Store credit only
- Comparable inconsistency to Paradigm. Avoid for critical studies
- The table above distills what separates operationally legitimate suppliers (they ship a product) from analytically rigorous suppliers (what ships matches the label within measurable tolerances). Paradigm Peptides falls into the former category. They're not a scam operation, but their quality assurance processes don't meet the standards serious research demands.
- Real Peptides' approach differs structurally: every batch undergoes small-scale synthesis with amino-acid sequencing verification before lyophilisation, and each vial ships with a scannable QR code linking to that specific batch's HPLC and mass spec data. This isn't marketing differentiation. It's operational philosophy. Research-grade peptides require precision manufacturing at every step, not bulk synthesis with spot-check testing. You can explore this methodology across compounds like Thymalin or Dihexa where batch traceability is non-negotiable.